Metastatic Breast Cancer Awareness Day: What You Need to Know
For Metastatic Breast Cancer Awareness Day on October 13th, 2019, here’s a round-up of fast facts and the latest news and updates in this disease space.
BY Jessica Skarzynski
PUBLISHED October 13, 2019
For Metastatic Breast Cancer Awareness Day on October 13th, 2019, here’s a round-up of fast facts and the latest news and updates in this disease space:
- Three-time cancer survivor and one-woman show writer and performer, Valerie David, sat down with CURE to discuss her experiences with non-Hodgkin lymphoma, then stage 2 breast cancer and, most recently, metastatic stage 4 breast cancer.
- After being diagnosed with metastatic breast cancer in January 2015, CURE contributor Martha Carlson shares some tips on how to responsibly search for healthcare information online.
- The Food and Drug Administration recently approved Piqray (alpelisib) for the treatment of certain postmenopausal women, and men, with HR-positive, HER2-negative, PIK3CA-mutated, advanced or metastatic breast cancer.
- Eight-year metastatic “thriver” Stephanie Seban explains the hurdles she faced as she received the wrong treatment for nearly five years.
- In another FDA action, the subcutaneous use of Herceptin and Herceptin Hylecta in combination with chemotherapy was approved for the treatment of select patients with breast cancer.